| Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 103.38B | 84.00B | 75.89B | 73.75B | 71.75B |
| Gross Profit | 28.69B | 41.83B | 35.72B | 35.49B | 35.47B |
| EBITDA | 52.39B | 53.40B | 47.55B | 47.75B | 47.68B |
| Net Income | 36.67B | 37.48B | 33.24B | 32.84B | 32.43B |
Balance Sheet | |||||
| Total Assets | 1.08T | 1.07T | 1.06T | 1.01T | 1.00T |
| Cash, Cash Equivalents and Short-Term Investments | 29.47B | 23.26B | 29.09B | 20.47B | 37.57B |
| Total Debt | 461.19B | 457.89B | 450.19B | 423.39B | 419.49B |
| Total Liabilities | 533.79B | 528.13B | 518.89B | 491.21B | 487.14B |
| Stockholders Equity | 542.83B | 541.42B | 538.40B | 517.76B | 516.45B |
Cash Flow | |||||
| Free Cash Flow | 29.19B | 25.33B | -4.67B | 11.73B | 46.54B |
| Operating Cash Flow | 67.79B | 72.51B | 59.89B | 68.59B | 49.98B |
| Investing Cash Flow | -37.05B | -51.20B | -64.73B | -58.61B | -3.41B |
| Financing Cash Flow | -31.96B | -26.76B | 14.17B | -27.62B | -30.83B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥135.05B | 8.79 | ― | 6.26% | 55.69% | 24.75% | |
69 Neutral | ¥847.81B | 12.44 | 6.59% | 3.83% | -1.97% | -2.16% | |
66 Neutral | ¥1.14T | 16.01 | 5.94% | 3.40% | -14.70% | -7.58% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
64 Neutral | ¥231.12B | 10.22 | ― | 4.63% | 19.76% | 7.95% | |
63 Neutral | ¥538.75B | 9.97 | ― | 4.10% | 5.25% | 19.44% | |
62 Neutral | ¥308.47B | 11.71 | ― | 3.94% | 30.30% | -25.37% |